• Return to Headlines

After Yesterday's Decline of 1.55%, Impax Laboratories Offers Investors Better Value

By Shiri Gupta

Impax Laboratories (NASDAQ:IPXL) traded in a range yesterday that spanned from a low of $15.35 to a high of $16.10. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $15.95 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend recommended that subscribers consider buying shares of Impax Laboratories on March 27th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $11.75. Since that recommendation, shares of Impax Laboratories have risen 37.0%. We continue to monitor IPXL for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

In the past 52 weeks, shares of Impax Laboratories have traded between a low of $7.75 and a high of $52.10 and are now at $15.72, which is 103% above that low price. In the last five trading sessions, the 50-day moving average (MA) has remained constant while the 200-day MA has slid 0.9%.

Keywords: rebounders impax laboratories

Ticker(s): IPXL